What is Cannabis Strategic Ventures (NUGS) stock price today?

Cannabis Strategic Ventures (NUGS) is currently trading at $0.01, up 20.79% today.

What is NUGS P/E ratio?

Cannabis Strategic Ventures's P/E ratio is -0.22. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is NUGS return on equity (ROE)?

Cannabis Strategic Ventures's return on equity (ROE) is 102.41%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Cannabis Strategic Ventures's market cap?

Cannabis Strategic Ventures has a market capitalization of $2.25M.

OTC · Drug Manufacturers - Specialty & Generic

Cannabis Strategic Ventures (NUGS) Stock

$0.01 +20.79% OTC: NUGS Healthcare

Cannabis Strategic Ventures specializes in cultivating cannabis products across the United States. Beyond its growing operations, the firm actively fosters new ventures, expands existing operations, and forms strategic alliances within the broader cannabis ecosystem and its supporting sectors.

Valuation

Metric	Value
Price	$0.01
Market Cap	$2.25M
P/E Ratio	-0.22
P/B Ratio	-0.21
P/S Ratio	0.23
EPS (TTM)	$-0.03
52-Week High	$0.09
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	102.41%
ROA	-76.96%
ROCE	117.77%
Gross Margin	9.35%
Operating Margin	-73.26%
Net Margin	-87.25%
Debt/Equity	-1.56
Current Ratio	0.12

Annual Financials (USD)

Metric	2017	2018	2019	2020	2021
Revenue	$0	$1.0M	$2.0M	$15.0M	$10.0M
Operating Profit	$-4.0M	$-21.0M	$-9.0M	$-5.0M	$-7.0M
Net Profit	$-8.0M	$-21.0M	$-9.0M	$-6.0M	$-9.0M
EPS	$0.00	$-0.08	$-0.04	$-0.02	$-0.03
Op Margin	-1291.0%	-3008.1%	-362.4%	-36.3%	-73.3%

Balance Sheet (USD)

Metric	2017	2018	2019	2020	2021
Total Assets	$12.0M	$3.0M	$18.0M	$16.0M	$11.0M
Total Liabilities	$2.0M	$2.0M	$24.0M	$24.0M	$20.0M
Cash	$0	$0	$0	$0	$0
Borrowings	$0	$1.0M	$21.0M	$22.0M	$14.0M

Latest News

Cannabis Strategic Ventures, Inc. (OTC: NUGS) Signs Letter of Intent to Acquire Adport, a Mobile Out-of-Home Advertising Technology Business GlobeNewswire · Sep 10, 2026

Cash Flow (USD)

Metric	2017	2018	2019	2020	2021
Operating Cash Flow	$-1.0M	$-3.0M	$-8.0M	$-4.0M	$-1.0M
Investing Cash Flow	$0	$0	$-7.0M	$-2.0M	$0
Financing Cash Flow	$0	$2.0M	$0	$0	$0
Net Cash Flow	$0	$0	$0	$0	$0
Free Cash Flow	$-1.0M	$-3.0M	$-11.0M	$-5.0M	$-1.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-2.82
FCF Yield	-63.43%
Quick Ratio	0.02
Interest Coverage	-5.32
Return 1Y	6000.00%
Return 3Y	38.64%
Return 5Y	-86.93%

Peer Comparison

Ticker	Price	Change	Market Cap	Div Yield
AOLSAeolus Pharmaceuticals, Inc.	$0.00	—	$15209	0.00%
CBGIThe CannaBusiness Group, Inc.	$0.00	—	$1831	0.00%
FIORFFiore Cannabis Ltd.	$0.00	—	$1971	0.00%
HCANFHalo Collective Inc.	$0.00	—	$15081	0.00%
HSMDHealthcare Solutions Management Group, Inc.	$0.00	—	$18443	0.00%

About Cannabis Strategic Ventures

Cannabis Strategic Ventures is headquartered in US.

Cannabis Strategic Ventures (NUGS) stock trades at $0.01 with a market capitalization of $2.25M. The stock is valued at a price-to-earnings (P/E) ratio of -0.22, price-to-book of -0.21, price-to-sales of 0.23. Over the past 52 weeks the stock has ranged between $0.00 and $0.09, and currently trades 88.9% below its 52-week high.

On profitability, Cannabis Strategic Ventures generates a return on equity (ROE) of 102.41% — well above the market average, a sign of a high-quality business, return on capital employed of 117.77%, an operating margin of -73.26%, a net profit margin of -87.25%.

Official website: www.cannabisstrategic.com